文献速递关节外科

外科医生价值记分卡与择期初次髋膝关节置换术价值改善相关

A Surgeon Scorecard Is Associated with Improved Value in Elective Primary Hip and Knee Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2019-01-01

该研究回顾性分析某城市三级医疗中心在引入非盲法外科医生价值记分卡前后9个月的全关节置换术患者结局与医院成本。记分卡实施后,平均总成本下降8.7%,平均总直接可变成本下降17.1%,假体成本下降5.3%,术后住院时间缩短0.2天至1.7天,临床结局无显著差异。

要点

  • 非盲法外科医生价值记分卡实施9个月后,全关节置换术平均总成本下降8.7%,从17996美元降至16426美元(p<0.001)。
  • 平均总直接可变成本下降17.1%,从10945美元降至9070美元(p<0.001),假体成本下降5.3%(p<0.001)。
  • 术后住院时间缩短0.2天至1.7天(p<0.001),家庭出院率、30天再入院率和90天再入院率有改善但差异无统计学意义(p>0.05)。

核心结论

  • 实施针对下肢关节置换术的外科医生价值记分卡与医院总成本和直接可变成本降低、假体成本降低、成本变异减少及术后住院时间缩短相关,且未损害临床结局。

研究设计与样本

  • 回顾性分析某城市三级医疗中心在引入外科医生价值记分卡前及引入后9个月的全关节置换术患者结局与医院成本。
  • 2016年8月至2017年5月,骨科医生每月收到非盲法外科医生价值记分卡,汇总按医生归因于诊断相关组470(无合并症或并发症的主要下肢关节置换术)患者的滚动6个月结果。
  • 实施前,医生接受了记分卡教育,并参与制定概述纳入指标定义与计算方法的文件。
  • 记分卡指标分为5类:患者人口学特征、患者结局(如住院时间、出院去向、再入院)、患者体验、财务和运营(如手术时间)。
  • 本研究选择财务(成本)指标和患者结局作为分析的关键绩效指标。

主要发现

  • 非盲法外科医生价值记分卡分发9个月后,全关节置换术平均总成本下降8.7%,从17996美元降至16426美元(p<0.001)。
  • 平均总直接可变成本下降17.1%,从10945美元降至9070美元(p<0.001),假体成本下降5.3%(p<0.001)。
  • 住院时间缩短0.2天至1.7天(p<0.001)。
  • 家庭出院率、30天再入院率和90天再入院率有改善,但差异无统计学意义(p>0.05)。

关键数值与推荐

  • 连续变量在假定正态分布时使用t检验,假定非正态分布时使用Mann-Whitney检验;分类变量使用卡方检验;显著性定义为p<0.05。
  • 记分卡指标分为5类:患者人口学特征、患者结局(如住院时间、出院去向、再入院)、患者体验、财务和运营(如手术时间)。

临床怎么用

  • 与外科医生分享非盲法临床和财务结局可能促进共同问责文化,并可能使外科医生有能力在医疗服务提供中改进基于价值的决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite increasing interest in total joint arthroplasty registries, evidence of the impact of physician-level performance on the value of care provided to patients undergoing hip and knee arthroplasty is lacking. The purpose of this study was to examine the effectiveness of an unblinded orthopaedic surgeon-specific value scorecard in improving patient outcomes and reducing hospital costs. METHODS: We retrospectively analyzed patient outcomes and hospital costs associated with total joint arthroplasties before and 9 months after the introduction of a Surgeon Value Scorecard at an urban tertiary care center. From August 2016 to May 2017, orthopaedic surgeons received an unblinded monthly Surgeon Value Scorecard summarizing a rolling 6-month view of results by surgeon for patients attributed to Diagnosis Related Group 470 (major lower-extremity arthroplasty without comorbidity or complication). Prior to implementation, surgeons were educated on the scorecard and participated in the development of a document outlining the definition and calculation of included metrics. Scorecard metrics were grouped into 5 categories: patient demographic characteristics, patient outcomes (for example, length of stay, discharge disposition, readmissions), patient experience, financial, and operational (for example, operative times). Financial (cost) measures and patient outcomes were selected as the key performance indicators analyzed in this study. Continuous variables were analyzed using the t test when a normal distribution was assumed and using Mann-Whitney tests when a non-normal distribution was assumed. Categorical variables were compared using chi-square tests. Significance was defined as p < 0.05. RESULTS: After 9 months of unblinded Surgeon Value Scorecard distribution, the mean total costs for total joint arthroplasties decreased by 8.7%, from $17,996 to $16,426 (p < 0.001). The mean total direct variable costs decreased by 17.1% from $10,945 to $9,070 (p < 0.001), and implant costs decreased by 5.3% (p < 0.001). Length of stay also decreased by 0.2 day to 1.7 days (p < 0.001), and, although there was improvement in the home-discharge rate, 30-day readmission rate, and 90-day readmission rate, the differences were not significant (p > 0.05). CONCLUSIONS: The implementation of a surgeon-specific value scorecard for lower-extremity joint arthroplasties was associated with reduced total and direct variable hospital costs, reduced implant costs, decreased variation in costs, and reduced postoperative length of stay, without compromising clinical outcomes. CLINICAL RELEVANCE: Sharing unblinded clinical and financial outcomes with surgeons may promote a culture of shared accountability and may empower surgeons to improve value-based decision-making in care delivery.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Winegar AL, Jackson LW, Sambare TD, et al. A Surgeon Scorecard Is Associated with Improved Value in Elective Primary Hip and Knee Arthroplasty. J Bone Joint Surg Am. 2019. PMID: 30653045. doi:10.2106/JBJS.17.01553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。